ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,104Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 198

$1.05M Total Retail Price of All Prescriptions

Rank: 7 out of 198

510 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 16,388 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
WARFARIN SODIUM 1,124 1,020 1 7
FUROSEMIDE 786 768 2 5
LEVOTHYROXINE SODIUM 731 679 3 1
OMEPRAZOLE 686 557 4 3
GABAPENTIN 533 503 5 14
SIMVASTATIN 502 431 6 2
HYDROCODONE-ACETAMINOPHEN 493 432 S3 7 8
AMLODIPINE BESYLATE 467 417 8 4
POTASSIUM CHLORIDE 439 413 9 9
DONEPEZIL HCL 332 321 10 28
TRAMADOL HCL 324 308 11 15
LISINOPRIL 303 274 12 6
NAMENDA 265 252 13 33
QUETIAPINE FUMARATE 250 226 14 76
SERTRALINE HCL 239 221 15 25
CITALOPRAM HBR 237 226 16 20
METOPROLOL TARTRATE 221 187 17 10
POLYETHYLENE GLYCOL 3350 215 196 18 41
METFORMIN HCL 194 181 19 13
TAMSULOSIN HCL 186 152 20 27
RANITIDINE HCL 184 181 21 54
CARVEDILOL 176 158 22 24
MIRTAZAPINE 170 154 23 44
METOPROLOL SUCCINATE 144 144 24 11
CARBIDOPA-LEVODOPA 144 134 24 71
PANTOPRAZOLE SODIUM 124 104 26 31
ROPINIROLE HCL 116 96 27 74
ESCITALOPRAM OXALATE 114 97 28 53
IPRATROPIUM-ALBUTEROL 112 87 29 180
RAMIPRIL 112 107 29 72
RISPERIDONE 111 92 31 82
CLONIDINE HCL 111 93 31 52
ATENOLOL 110 109 33 17
CYMBALTA 110 77 33 48
HYDROCHLOROTHIAZIDE 108 93 35 16
LEVOFLOXACIN 108 92 35 81
NITROFURANTOIN MONO-MACRO 106 90 37 231
NOVOLOG 102 82 38 107
TRAZODONE HCL 101 63 39 50
OXYBUTYNIN CHLORIDE 97 77 40 89
ALENDRONATE SODIUM 95 95 41 21
LIDODERM 94 84 42 160
DIGOXIN 92 91 43 43
GLIPIZIDE 90 82 44 62
BACLOFEN 88 44 45 183
LEVETIRACETAM 86 58 46 153
SEROQUEL 85 64 47 168
FLUTICASONE PROPIONATE 85 60 47 39
IBUPROFEN 82 65 49 124
BISOPROLOL FUMARATE 82 75 49 87
ISOSORBIDE MONONITRATE ER 82 82 49 60
LANTUS 80 72 52 46
NYSTATIN 79 66 53 148
OXYBUTYNIN CHLORIDE ER 78 78 54 109
FAMOTIDINE 76 51 55 57
LAMOTRIGINE 69 33 56 182
LATANOPROST 68 68 57 209
PREDNISONE 67 60 58 29
DIVALPROEX SODIUM 66 66 59 122
MUPIROCIN 66 52 59 216
METFORMIN HCL ER 65 57 61 64
ALLOPURINOL 65 64 61 23
BUDESONIDE 64 22 63 256
VENLAFAXINE HCL ER 62 60 64 84
VESICARE 62 55 64 77
PAROXETINE HCL 60 55 66 65
LACTULOSE 59 25 67 181
GEMFIBROZIL 58 29 68 110
DIVALPROEX SODIUM ER 58 44 68 186
GLIMEPIRIDE 58 52 68 35
VALPROIC ACID 58 48 68 269
AGGRENOX 57 57 72 164
OLANZAPINE 57 46 72 162
ABILIFY 56 32 74 177
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 43 74 90
TRAVATAN Z 55 46 76 273
CYCLOBENZAPRINE HCL 55 15 R 76 67
FLUOXETINE HCL 55 38 76 78
NYSTOP 55 48 76 189
SPIRONOLACTONE 54 49 80 37
SODIUM CHLORIDE 54 40 80 278
PRIMIDONE 52 37 82 200
NEXIUM 51 50 83 40
FINASTERIDE 50 50 84 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.